X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE PANACEA BIOTECH SUVEN LIFE/
PANACEA BIOTECH
 
P/E (TTM) x 18.0 -6.4 - View Chart
P/BV x 3.6 1.9 190.2% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SUVEN LIFE   PANACEA BIOTECH
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
PANACEA BIOTECH
Mar-14
SUVEN LIFE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs251149 168.7%   
Low Rs15582 188.3%   
Sales per share (Unadj.) Rs49.184.1 58.4%  
Earnings per share (Unadj.) Rs9.7-18.3 -53.1%  
Cash flow per share (Unadj.) Rs11.4-6.7 -170.1%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs60.383.7 72.0%  
Shares outstanding (eoy) m127.2861.25 207.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.4 300.9%   
Avg P/E ratio x20.9-6.3 -330.9%  
P/CF ratio (eoy) x17.8-17.2 -103.3%  
Price / Book Value ratio x3.41.4 243.9%  
Dividend payout %15.40-   
Avg Mkt Cap Rs m25,8257,074 365.1%   
No. of employees `0001.12.8 39.0%   
Total wages/salary Rs m6131,449 42.3%   
Avg. sales/employee Rs Th5,832.61,874.1 311.2%   
Avg. wages/employee Rs Th571.5527.0 108.5%   
Avg. net profit/employee Rs Th1,153.8-407.7 -283.0%   
INCOME DATA
Net Sales Rs m6,2535,154 121.3%  
Other income Rs m233100 233.2%   
Total revenues Rs m6,4855,254 123.4%   
Gross profit Rs m1,982-766 -258.6%  
Depreciation Rs m213711 30.0%   
Interest Rs m461,503 3.1%   
Profit before tax Rs m1,955-2,881 -67.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m71817 4,275.3%   
Profit after tax Rs m1,237-1,121 -110.3%  
Gross profit margin %31.7-14.9 -213.2%  
Effective tax rate %36.7-0.6 -6,298.9%   
Net profit margin %19.8-21.8 -90.9%  
BALANCE SHEET DATA
Current assets Rs m5,6223,810 147.6%   
Current liabilities Rs m1,1688,365 14.0%   
Net working cap to sales %71.2-88.4 -80.6%  
Current ratio x4.80.5 1,057.2%  
Inventory Days Days81156 52.3%  
Debtors Days Days3667 53.4%  
Net fixed assets Rs m3,32514,480 23.0%   
Share capital Rs m12761 207.7%   
"Free" reserves Rs m7,547903 835.7%   
Net worth Rs m7,6745,127 149.7%   
Long term debt Rs m145,832 0.2%   
Total assets Rs m9,13519,433 47.0%  
Interest coverage x43.2-0.9 -4,716.5%   
Debt to equity ratio x01.1 0.2%  
Sales to assets ratio x0.70.3 258.1%   
Return on assets %14.02.0 715.1%  
Return on equity %16.1-21.9 -73.7%  
Return on capital %26.03.6 715.9%  
Exports to sales %024.5 0.0%   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNA1,264 0.0%   
Imports (cif) Rs mNA525 0.0%   
Fx inflow Rs m5,0661,539 329.1%   
Fx outflow Rs m2,001942 212.4%   
Net fx Rs m3,065597 513.2%   
CASH FLOW
From Operations Rs m699599 116.7%  
From Investments Rs m-6-438 1.4%  
From Financial Activity Rs m-577-303 190.7%  
Net Cashflow Rs m116-141 -82.3%  

Share Holding

Indian Promoters % 63.4 74.5 85.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 0.0 1.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 23.6 154.7%  
Shareholders   37,287 10,259 363.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   CIPLA  PFIZER  NATCO PHARMA  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 150 Points Higher; Banking Stocks Witness Buying(Closing)

Indian share markets continued their momentum and ended the day on a positive note. Gains were largely seen in the banking sector, consumer durables sector and realty sector.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Dec 13, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS